logo
Book a meeting
Vitranu

Vitranu

Biotechnology, 7720 Rivers Edge Dr, Columbus, Ohio, 43235, United States, 1-10 Employees

vitranu.com

  • twitter
  • LinkedIn

phone no Phone Number: +12*********

Who is VITRANU

Vitranu is developing a Tunable Extended Release Capsule (TERCTM) for sustained delivery of therapeutics to the eye via intravitreal injection. TERCTM is manufactured with biodegradable p...

Read More

lock icon Get Full Access
map
  • 7720 Rivers Edge Dr, Columbus, Ohio, 43235, United States Headquarters: 7720 Rivers Edge Dr, Columbus, Ohio, 43235, United States
  • 2020 Date Founded: 2020
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VITRANU

Vitranu Org Chart and Mapping

Employees
Emily Rybak

Emily Rybak

Product Development Manager

See Full Org Chart arrow
email-formate-icon
View Email Formats for Vitranu
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Vitranu

Answer: Vitranu's headquarters are located at 7720 Rivers Edge Dr, Columbus, Ohio, 43235, United States

Answer: Vitranu's phone number is +12*********

Answer: Vitranu's official website is https://vitranu.com

Answer: Vitranu's revenue is Under $1 Million

Answer: Vitranu's SIC: 2836

Answer: Vitranu's NAICS: 541714

Answer: Vitranu has 1-10 employees

Answer: Vitranu is in Biotechnology

Answer: Vitranu contact info: Phone number: +12********* Website: https://vitranu.com

Answer: Vitranu is developing a Tunable Extended Release Capsule (TERCTM) for sustained delivery of therapeutics to the eye via intravitreal injection. TERCTM is manufactured with biodegradable polymers using novel electrospinning technology to produce a double-walled, tunable capsule that can be filled with unaltered biologic or small molecule therapeutics. By modifying the electrospinning process parameters, capsules can be made with defined pore sizes and "tuned" to deliver the payload with the desired drug elution profile. This patented and unique approach provides a platform technology to fulfill the unmet need of sustained, controllable ophthalmic drug delivery.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access